The project to create the XNA-HUB platform receives a significant boost thanks to PERTE funding. The platform will design therapeutic molecules based on modified nucleic acids using supercomputing tec...
Read moreA study on Parkinson’s published in the Journal of Clinical Investigation Insight reveals brain cells called astrocytes to be reactive, attacking and removing nervous cells that generate dopamine in...
Read moreUn estudio propone un novedoso enfoque para frenar la degeneración neuromuscular en pacientes con Esclerosis Lateral Amiotrófica (ELA). Esta patología provoca la pérdida de neuronas motoras y la p...
Read moreThe multi-faceted consortium proposes an innovative approach to overcome these limitations and to construct a pathway for developing improved vectors for clinical gene transfer. By synergising French,...
Read moreApproximately 80% of RRDs are genetic in origin, while the remaining 20% are the result of infectious, immunological, degenerative or proliferative diseases. The most important problem faced by patien...
Read moreIn the fight against these diseases, at IRB Barcelona, they are committed to interdisciplinary research through new projects aimed at better understanding rare diseases and developing new therapies an...
Read moreA research team led by the Institut de Neurociències at the UAB has managed to generate and validate a new animal model. This model enables the examination of the initial phases of Parkinson's diseas...
Read moreBraingaze’s innovative technology leverages proprietary biomarkers of eye micromovements, casual video games and deep learning (AI) algorithms. The diagnostic solutions offer cutting-edge accuracy a...
Read moreBraingaze, the University of Barcelona’s digital cognitive health spin-off, successfully closed a €1.5 million investment round. The funding will accelerate the clinical and business development o...
Read moreA collaborative international study, led by researchers at CIC bioGUNE – member of BRTA – and CIBERINFEC, has achieved a crucial milestone in the fight against prion diseases by developing a gr...
Read moreA study led by the University of Barcelona and the Bellvitge Biomedical Research Institute (IBIDELL) reveals that the TDP-43 protein is essential for forming a stable and mature blood vessel network i...
Read moreEl trabajo ha caracterizado una variante genética en el gen SIRPB1, que afecta el modo en el que el sistema inmune lucha contra los depósitos de beta-amiloide, causantes de esta patología.
Read more